NEW YORK (GenomeWeb) – Sengenics said this week that it has exclusively partnered with Sequenom to launch that company's VisibiliT non-invasive prenatal test in Thailand, Indonesia, and Brunei.

VisibiliT targets women with average-risk pregnancies and has a lower cost and content than Sequenom's MaterniT21 Plus NIPT. Using a maternal blood sample, it analyzes chromosomal material in cell-free DNA of pregnant women to provide information about common fetal trisomies. The test reports a risk score for trisomies 21, 18, and 13, as well as fetal gender.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.